Z. Ma

1.7k total citations
70 papers, 1.2k citations indexed

About

Z. Ma is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Z. Ma has authored 70 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 14 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Z. Ma's work include Cancer Immunotherapy and Biomarkers (12 papers), Lung Cancer Treatments and Mutations (10 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Z. Ma is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Lung Cancer Treatments and Mutations (10 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Z. Ma collaborates with scholars based in China, United States and Taiwan. Z. Ma's co-authors include Bock G. Chan, Lawrence J. Porter, Yongxiang Yang, Chao Fan, Chao Deng, Yan Sun, Shuai Jiang, Wei Yi, Jinlei Lv and Zhiming Cui and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Cell Metabolism.

In The Last Decade

Z. Ma

56 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Z. Ma China 16 324 159 124 117 114 70 1.2k
Tsui‐Chun Tsou Taiwan 32 654 2.0× 215 1.4× 121 1.0× 112 1.0× 223 2.0× 79 2.4k
Marcelo González Chile 22 282 0.9× 48 0.3× 79 0.6× 93 0.8× 68 0.6× 65 1.5k
Zhuoyu Li China 31 977 3.0× 225 1.4× 216 1.7× 81 0.7× 73 0.6× 76 2.3k
Eun‐Young Kim South Korea 22 810 2.5× 161 1.0× 130 1.0× 57 0.5× 70 0.6× 110 1.7k
Jinrong Zhang China 26 440 1.4× 63 0.4× 69 0.6× 57 0.5× 54 0.5× 102 2.2k
Liting Zhou China 24 437 1.3× 113 0.7× 152 1.2× 65 0.6× 58 0.5× 104 1.7k
Chao Cheng China 26 981 3.0× 98 0.6× 128 1.0× 54 0.5× 44 0.4× 96 2.2k
Dong China 20 669 2.1× 244 1.5× 94 0.8× 276 2.4× 90 0.8× 419 2.0k
Yongchun Zhang China 21 444 1.4× 76 0.5× 64 0.5× 46 0.4× 94 0.8× 117 1.4k
Luyi Li United States 27 973 3.0× 340 2.1× 122 1.0× 138 1.2× 55 0.5× 71 2.0k

Countries citing papers authored by Z. Ma

Since Specialization
Citations

This map shows the geographic impact of Z. Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z. Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z. Ma more than expected).

Fields of papers citing papers by Z. Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Z. Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z. Ma. The network helps show where Z. Ma may publish in the future.

Co-authorship network of co-authors of Z. Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Z. Ma. A scholar is included among the top collaborators of Z. Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Z. Ma. Z. Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ma, Z., et al.. (2025). Corporate climate risk perception and debt concentration. Finance research letters. 77. 107022–107022. 3 indexed citations
4.
Chen, Qi, Wanli Wu, Z. Ma, et al.. (2025). R406 and its structural analogs reduce SNCA/α-synuclein levels via autophagic degradation. Autophagy. 21(9). 1945–1961.
5.
Qiu, Yang, Renfeng Wang, Xinyu Zhang, et al.. (2025). NOX2 Contributes to High‐Frequency Outer Hair Cell Vulnerability in the Cochlea. Advanced Science. 12(34). e08830–e08830. 1 indexed citations
6.
Ma, Z., Xiaoyue Sun, Zijun Wang, et al.. (2025). The Dynamic Expression Changes of Neutrophil Extracellular Traps in Mouse Apical Periodontitis: A Potential Correlation With IL‐17. Journal of Immunology Research. 2025(1). 8039031–8039031.
7.
Zhou, Huiran, Xiaolong Wei, Z. Ma, et al.. (2025). Alumina-supported palladium modified by zeolite Socony Mobil-5 for highly efficient selective hydrogenation of acetylene in excess ethylene. Journal of Colloid and Interface Science. 696. 137907–137907.
8.
Bian, Xiaohui, et al.. (2025). Ethnomedicine, Botany, Phytochemistry, Pharmacology, Pharmacokinetics, and Toxicity of Rhizoma Corydalis: A Systematic Review. The American Journal of Chinese Medicine. 53(5). 1441–1476.
9.
Ma, Z., Xi Zhou, Lin Chen, Xing Chen, & Xianchao Feng. (2025). Dietary polyphenol-protein interactions: A literature review of advantages, binding mechanisms, and improved health applications. Food Research International. 222(Pt 1). 117721–117721.
10.
Ma, Z., et al.. (2025). Novel application of CHUANG BI FU biologic protein sponge in promoting peripheral nerve injury repair by regulating vascular regeneration. European journal of medical research. 30(1). 380–380. 1 indexed citations
11.
Shan, Wei, Cheng Qian, Xingju Yu, & Z. Ma. (2024). Inclusive finance and regional tourism economy: The role of total factor productivity. Finance research letters. 67. 105779–105779. 8 indexed citations
12.
Li, Xiaoxu, Yuqian Zhang, Hongxia Lin, et al.. (2024). Phytohormones involved in vascular cambium activity in woods: current progress and future challenges. Frontiers in Plant Science. 15. 1508242–1508242. 2 indexed citations
13.
Wang, Li, et al.. (2024). 488P ITGA2 promotes glioma cell stemness and progression by activating the AKT pathway. Annals of Oncology. 35. S422–S423. 1 indexed citations
14.
Li, Zhaoyang, Ziying Wang, Hang Zhang, et al.. (2024). P53 upregulation by USP7-engaging molecular glues. Science Bulletin. 69(12). 1936–1953. 5 indexed citations
15.
Ding, Peng, Xiaoyan Zhang, Xin Zhou, et al.. (2023). Ubiquitin-specific protease 28: the decipherment of its dual roles in cancer development. Experimental Hematology and Oncology. 12(1). 27–27. 12 indexed citations
17.
Zhao, Jun, Z. Ma, Jiuwei Cui, et al.. (2018). P1.04-36 Tislelizumab Combined With Chemotherapy as First-Line Treatment in Chinese Patients With Advanced Lung Cancer. Journal of Thoracic Oncology. 13(10). S540–S540. 1 indexed citations
18.
Zhou, C.Z., Christian Caglevic, Jianying Zhou, et al.. (2017). KEYNOTE-033: Phase 3 study of pembrolizumab versus docetaxel in patients with previously treated non–small-cell lung cancer (NSCLC). Annals of Oncology. 28. x143–x143. 3 indexed citations
19.
Wang, Yajun, et al.. (2008). Effects of enhanced UV-B radiation on fitness of an alpine species Cerastium glomeratum Thuill. Journal of Plant Ecology. 1(3). 197–202. 9 indexed citations
20.
Bi, Wenfang, George P. Hemstreet, Nabih R. Asal, et al.. (1993). Field molecular epidemiology. Feasibility of monitoring for the malignant bladder cell phenotype in a benzidine-exposed occupational cohort.. PubMed. 35(1). 20–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026